
Braiin Ltd (NASDAQ:BRAI – Free Report) – Stock analysts at Maxim Group issued their FY2026 EPS estimates for shares of Braiin in a note issued to investors on Monday, June 15th. Maxim Group analyst A. Klee expects that the company will post earnings of ($0.02) per share for the year. Maxim Group currently has a “Buy” rating and a $10.00 price target on the stock. Maxim Group also issued estimates for Braiin’s FY2027 earnings at $0.01 EPS and FY2028 earnings at $0.05 EPS.
A number of other equities research analysts have also issued reports on the company. Wall Street Zen upgraded Braiin from a “sell” rating to a “hold” rating in a research note on Sunday, May 31st. Weiss Ratings started coverage on Braiin in a report on Wednesday, May 6th. They issued a “sell (e+)” rating for the company. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $10.00.
Braiin Price Performance
Shares of NASDAQ BRAI opened at $7.49 on Wednesday. The firm has a fifty day moving average of $7.83. Braiin has a 12-month low of $4.19 and a 12-month high of $33.00.
Key Braiin News
Here are the key news stories impacting Braiin this week:
- Positive Sentiment: Maxim Group initiated coverage on Braiin Ltd with a buy rating and a $10.00 price target, signaling potential upside and likely boosting investor confidence. Braiin is now covered by Maxim Group. They set a “buy” rating and a $10.00 price target on the stock. This represents a 33.5% upside from the current price of $7.49. Read More: Benzinga, The Fly, Zacks.com
- Neutral Sentiment: The rest of the recent items are general brain-health and neuroscience articles, including topics like brain implants, memory, and brain aging. These are not directly tied to Braiin Ltd’s business or financial results, so they are unlikely to be a major driver of the stock today.
About Braiin
Braiin Limited is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (“AI/ML”) technologies to deliver actionable insights across high-growth verticals: Agriculture, Property Technology, and Customer Experience as a Service (“CXaaS”). Our platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. Our first commercial focus is on the agriculture technology sector, where we have successfully deployed our AI-powered solutions across multiple implementations.
Recommended Stories
- Five stocks we like better than Braiin
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Braiin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braiin and related companies with MarketBeat.com's FREE daily email newsletter.
